Deals
Alva, a stakeholder intelligence platform has partnered with Ballast Research and Hamilton Place Strategies (HPS). The partnership was supported by a majority investment in alva by Falfurrias Capital Partners (FCP), formalising the relationship between the leaders across corporate stakeholder management. The partnership and investment follows FCP’s earlier majority investments in Ballast Research and HPS.
Headquartered in London, UK, alva is a stakeholder intelligence platform that provides data-rich, real-time technology to companies across industries, including financial services, consumer, healthcare, and professional services. Built on award-winning Natural Language Processing technology, alva delivers the richest and most accurate insights based on the analysis
Ardian has arranged a unitranche facility with the participation of a wholly-owned subsidiary division of Caisse de dépôt et placement du Québec (CDPQ), to support the investment of Naxicap Partners in Lagarrigue, a global specialist in large scale external orthopaedic devices for the treatment of disabilities, alongside the Company’s management.
Headquartered in Toulouse and founded in 1976, the French-based Group has extended its presence since 2016 into neighbouring countries, such as Belgium, Switzerland and Spain. This development was enabled by an active acquisition strategy, which now results in over 30 per cent of its sales being achieved internationally.
Together with
Artios Pharma Limited (Artios), a DNA Damage Response (DDR) company exploiting a broad DDR-based platform and small molecule drug discovery capabilities to develop a diverse pipeline of product candidates for the treatment of cancer, has completed a USD153 million (GBP110 million) Series C financing to fund further development of its clinical-stage pipeline.
The oversubscribed financing was co-led by Omega Funds and TCG X. Additional investors include Avidity Partners, Invus, Deep Track Capital, Sofinnova Partners, Tetragon Financial Group, RTW Investments LP, Soleus Capital, Piper Heartland Healthcare Capital, CaaS Capital Management, and Schroders Capital. These new investors join existing investors Arix Bioscience
SEDNA, an intelligent communications system for high-performance teams at leading companies like Glencore, Norden, and Bunge, has secured USD34 million in Series B funding.
Levine Leichtman Capital Partners (LLCP), a Los Angeles-based private equity firm, has sold its portfolio company FlexXray Holdings, LLC (FlexXray) to Warburg Pincus and Tilia Holdings. Financial terms of the transaction have not been disclosed.
FlexXray is a leading provider of x-ray inspection services focused on food safety. The Company assists Fortune 100 food manufacturers with regulatory compliance and food safety issues by identifying and removing foreign contaminants. Hundreds of manufacturing plants throughout North America rely on FlexXray’s expertise and customer service to salvage valuable products when contamination events occur in the normal course of the food manufacturing process. FlexXray
Zenput, a specialist in operations execution solutions, has secured USD27 million in a Series C financing round led by Golub Capital with participation by existing investors, including Jackson Square Ventures, MHS Capital, and Goldcrest Capital.
This brings the company’s total funding to over USD47 million, on the heels of approximately 100 per cent revenue growth over the past year.
Founded in 2012, Zenput’s cloud-based operations execution platform is now used in over 60,000 locations across 100-plus countries by regional and global multi-unit operators, including Chipotle, Domino’s, PF Chang’s, Five Guys, Smart & Final, and 7-Eleven, to automate how operating
Sproutl, a UK gardening tech start-up that aims to open up gardening to a whole new generation of gardeners and get everyone to plant something, has today launched a curated online marketplace that celebrates the best brands and businesses in the gardening industry, having raised USD9 million in a seed funding round led by Index Ventures with participation from Ada Ventures.
Azora, a Madrid-based European private equity manager and one of Spain’s leading real assets investors, is to dispose of a 1.2GW Spanish renewable energy portfolio to Eni, the Italian based global integrated energy company.
The portfolio comprises three operational onshore wind farms, an onshore wind farm under construction (totalling 230MW between them) and five large solar energy projects in advanced stages of development (totalling c.1GW). The assets are located in the regions of Andalucía, Castilla la Mancha, Castilla y León, Cataluña, Galicia and La Rioja.
Azora and Eni will work together to ensure the entry into production of the
AuthenticID, a provider of Identity Proofing solutions for large enterprises, has closed a USD100 million minority investment from Long Ridge Equity Partners, a technology-focused growth equity firm.
The investment will support AuthenticID’s continued expansion within telecommunications, financial services, government, and other consumer segments looking to establish trust and mitigate fraud, as well as enable AuthenticID to support the next generation of digital identity platforms.
AuthenticID provides identity proofing solutions to leading enterprises, including some of the country’s largest telecom carriers and financial institutions. The solution also powers many of the leading digital identity platforms globally. AuthenticID provides document-centric identity verification
Trilantic Europe, a private equity firm focused on mid-market transactions in Europe, has invested in the Smile Eyes Group, a specialist in the German ophthalmology market headquartered in Munich.
The investment is structured as a partnership between Trilantic Europe, the two co-founders of Smile Eyes Dres. Wiltfang and Bechmann and the management team, with the vision to implement a buy-and-build strategy in the German ophthalmology market. The financial details of this transaction are not disclosed.
Smile Eyes is a leading and highly specialised healthcare operator with a comprehensive service offering in the field of ophthalmology in various metropolitan regions in
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
